27.6 C
New York
Wednesday, June 3, 2026

Tag: infusions

GameStop’s Viral “Staplegate” Auction Transformed an Unexpected Incident into a Powerful Philanthropic Initiative

Charity auction raises $250,000 for Children's Miracle Network Hospitals NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Children's Miracle Network Hospitals (CMN Hospitals) announced that...

Exhale Launches Hawaiian Haze & Northern Lights: The New Faces of Premium Delta 8 Flower

Check out Exhale’s new premium Delta 8 flower strains: Hawaiian Haze for euphoria & Northern Lights for relaxation. Best option for balanced highs & therapeutic benefits.
Check out Exhale’s new premium Delta 8 flower strains: Hawaiian Haze for euphoria & Northern Lights for relaxation. Best option for balanced highs & therapeutic benefits.

Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer’s disease

The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and...

Lipton Doubles Down on Tea Innovation With First-Ever Concentrates and New Fruit & Herbal Line

Reimagined Tea Formats & Flavors Meet the Modern Lifestyle at Major Retailers This Summer ...

SIAL Shenzhen 2025: South China’s Premier Food & Beverage Sourcing Event Will Return This September

SHENZHEN, China, July 21, 2025 /PRNewswire/ -- From September 1 to 3, 2025, SIAL Shenzhen 2025, an exclusive gateway to South Asia's dynamic food and...

GBK & Sydenham Host Star-Studded Pre-ESPY Longevity Talent Lounge at Sydenham Clinic in Beverly Hills

The World's Top Athletes Received This Year's Hottest Gifts and Trips in Celebration on the Eve of One of the Biggest Nights in Sports LOS...

New Bass Center Clinic and Infusion Center to Facilitate Healing

PALO ALTO, Calif., July 15, 2025 /PRNewswire/ -- Lucile Packard Children's Hospital Stanford, the cornerstone of Stanford Medicine Children's Health, is proud to announce...

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at...

NEWTON, Mass., July 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), will present new findings at the upcoming Alzheimer's Association International Conference (AAIC®) 2025 in Toronto. The presentations include a cost savings analysis of the use of pTau217 as a screening tool in Acumen’s Phase 2 ALTITUDE-AD trial of sabirnetug as well as a nonclinical study evaluating the relative selectivity of sabirnetug to targeting AβOs versus Aβ monomers. The conference will be held July 27-31, 2025, both in-person and online.

H2O America Significantly Expands Texas Footprint with Texas Subsidiary’s Acquisition of Quadvest

More Than Doubles H2O America’s Connections in Texas and Increases Exposure to High Growth Houston Region

EnsembleIQ’s Progressive Grocer Unveils 2025 Top Women in Grocery

Whole Foods Market’s Christina Minardi and Lipton Teas and Infusions’ Racquel Harris Mason Chosen as Trailblazers
Whole Foods Market’s Christina Minardi and Lipton Teas and Infusions’ Racquel Harris Mason Chosen as Trailblazers

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInfusions